Adults who develop new-onset type 2 diabetes may have increased risk for obesity-related cancers compared with those without ...

The escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Medical experts have officially recognised a lesser-known diabetes, known as Type 5 diabetes. The condition is common among ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

A major new study from the UK has found that people newly diagnosed with type 2 diabetes (T2D) face a higher risk of ...

Feb. 28, 2025 — A study has provided new insights into the role of the brain as a crucial control center and the origin of obesity and type 2 diabetes. The hormone insulin plays a key role in ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel ...